Personality Disorders and Somatization
Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The exact date that your access expires will be indicated within the Course Summary box on this webpage.
Primary care physicians, nurses, mental health professionals, substance use disorder professionals, or any clinic staff who support behavioral health services.
Personality refers to enduring patterns of thought, feeling, motivation, self-regulation, and behaviors activated over time and across situations or in an interpersonally or adaptively significant situation. Personality plays such an important role, on the one hand, in life satisfaction and adaptation and, on the other, as a key diathesis for virtually every form of pathology in DSM-5 - from personality disorders themselves to anxiety, mood, and other disorders. This is why assessing personality is so essential for both clinical work and research.
- Describe various types of personality disorders.
- Define somatic symptom disorder.
- List management recommendations for personality disorders.
Recording date: August 13, 2021
Date of original release: August 27, 2021
Most recent review/update: August 27, 2021
Termination date: August 26, 2024
Janice Landy, MD
Dr. Landy joined UnityPoint Health in July 2018 as the Medical Director for Behavioral Health Services in the central region. She practices inpatient psychiatry at Iowa Lutheran Hospital and also sees patients in the UnityPoint Behavioral Health Urgent Care in Des Moines. She supervises residents in the Broadlawns-UnityPoint psychiatry residency program, and also supervises advanced practice providers at UnityPoint and Eyerly Ball Community Mental Health Center.
James Chambliss, MD
Third Year Resident, Broadlawns-UnityPoint Psychiatry Residency Program
- Medical School: University of Iowa
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Primary Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 0.75 AOA Category 2-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This live activity is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.
No commercial interest company provided financial support for this continuing education activity.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with commercial interest companies to disclose.
- Julie Baker, MPA, CHCEF, Planning Committee Member
- Bery Engebretsen, MD, Planning Committee Member
- Nicolas Foss, MS, IADC, BACC, ICGC-II, Planning Committee Member
- Gagandeep Lamba, MA, MS, MBA, Activity Director/Coordinator and Planning Committee Member
- Elizabeth Noble, Activity Coordinator
- Danielle O'Brien-Day, LMHC, CRC, Planning Committee Member
- Nicole Gastala, MD, Planning Committee Member
- Andrea Storjohann, MSN, ARNP, PMHNP-BC, CADC, Planning Committee Member
- James Chambliss, MD, Speaker
Relevant to the content of this educational activity, the following individual(s) have a conflict(s) with commercial interest companies to disclose.
- Janice Landy, MD, Planning Committee Member and Speaker - Does not have a conflict with a commercial interest company; however, does intend to discuss off-label uses of commercial products.
The speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director.
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
- 0.75 AMA PRA Category 1 Credits™
- 0.75 AOA Category 2B
- 0.75 CE Contact Hour(s)